Status:
UNKNOWN
Assessment of Functional Digestive and Genitourinary Outcomes in Patients With Rectal Cancer.
Lead Sponsor:
University Hospital, Caen
Conditions:
Rectal Cancer
Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Total mesorectal excision and neoadjuvant radio-chemotherapy have revolutionized the management of rectal cancer allowing an increase in survival (between 55 and 68% at 5 years) and allowing a decreas...
Eligibility Criteria
Inclusion
- Patients operated for a rectal adénocarcinoma with a curative aim with or without neo-adjuvating treatment in Calvados between January 1st, 2007 (date of recommendations for clinical practise) and december 31 th, 2014.
- Patients having their main address in the Calvados (at the time of diagnosis) and recorded in the register of digestive tumors of the Calvados.
- patients alive on first of january 2018 without local recurrence nor global recurrence
- patients able to understant a validated questionnaire.
Exclusion
- Dead patients
- patients with cancer recurrence
- Patient with severe cognitive disorders (confusions) preventing the good understanding of questionnaires.
Key Trial Info
Start Date :
March 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2018
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03459235
Start Date
March 20 2018
End Date
June 15 2018
Last Update
May 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
François baclesse Center - U1086 - Anticipe
Caen, Normandy, France, 14000